Charlotte Catharina Teneback, MD | |
111 Colchester Ave, East Pavilion 5, Burlington, VT 05401-1473 | |
(802) 863-8618 | |
Not Available |
Full Name | Charlotte Catharina Teneback |
---|---|
Gender | Female |
Speciality | Critical Care (intensivists) |
Experience | 20 Years |
Location | 111 Colchester Ave, Burlington, Vermont |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427110782 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
Champlain Valley Physicians Hospital Medical Ctr | Plattsburgh, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Incorporating pharmacists as members of the health care team in direct patient care roles is a viable solution to help improve U.S. health care, according to the results of a comprehensive, systematic review of the health care literature set to be published in the October 2010 edition of Medical Care.
People with mild Alzheimer's disease make more mistakes on a driving test than older people with no cognitive problems, according to a study published in the September 14 issue of Neurology, the scientific journal of the American Academy of Neurology.
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
› Verified 6 days ago
Entity Name | University Of Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Incorporating pharmacists as members of the health care team in direct patient care roles is a viable solution to help improve U.S. health care, according to the results of a comprehensive, systematic review of the health care literature set to be published in the October 2010 edition of Medical Care.
People with mild Alzheimer's disease make more mistakes on a driving test than older people with no cognitive problems, according to a study published in the September 14 issue of Neurology, the scientific journal of the American Academy of Neurology.
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
› Verified 6 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
Incorporating pharmacists as members of the health care team in direct patient care roles is a viable solution to help improve U.S. health care, according to the results of a comprehensive, systematic review of the health care literature set to be published in the October 2010 edition of Medical Care.
People with mild Alzheimer's disease make more mistakes on a driving test than older people with no cognitive problems, according to a study published in the September 14 issue of Neurology, the scientific journal of the American Academy of Neurology.
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
› Verified 6 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Incorporating pharmacists as members of the health care team in direct patient care roles is a viable solution to help improve U.S. health care, according to the results of a comprehensive, systematic review of the health care literature set to be published in the October 2010 edition of Medical Care.
People with mild Alzheimer's disease make more mistakes on a driving test than older people with no cognitive problems, according to a study published in the September 14 issue of Neurology, the scientific journal of the American Academy of Neurology.
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Charlotte Catharina Teneback, MD 111 Colchester Ave, East Pavilion 5, Burlington, VT 05401-1473 Ph: (802) 863-8618 | Charlotte Catharina Teneback, MD 111 Colchester Ave, East Pavilion 5, Burlington, VT 05401-1473 Ph: (802) 863-8618 |
News Archive
Incorporating pharmacists as members of the health care team in direct patient care roles is a viable solution to help improve U.S. health care, according to the results of a comprehensive, systematic review of the health care literature set to be published in the October 2010 edition of Medical Care.
People with mild Alzheimer's disease make more mistakes on a driving test than older people with no cognitive problems, according to a study published in the September 14 issue of Neurology, the scientific journal of the American Academy of Neurology.
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
› Verified 6 days ago
Nadia Ghallab, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Beach Conger, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4313 | |
Dr. Christopher Dwight Huston, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2264 | |
Beth Diane Kirkpatrick, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 802-847-4594 | |
Dr. Richard Frank Branda, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 S. Prospect St, Burlington, VT 05401 Phone: 802-847-3827 Fax: 802-847-3510 | |
Lauren Suggs, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Magdalena Anna Zeglin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |